Kinase Regulation by Hydrophobic Spine Assembly in Cancer

REFERENCES

• Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. 2002. The protein kinase complement of the human genome. Science 298:1912–1934. http://dx.doi.org/10.1126/science.1075762.
   PubMed Web of Science ®Google Scholar
• Taylor SS, Kornev AP. 2011. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36:65–77. http://dx.doi.org/10.1016/j.tibs.2010.09.006.
   PubMed Web of Science ®Google Scholar
• Kornev AP, Taylor SS, Ten Eyck LF. 2008. A helix scaffold for the assembly of active protein kinases. Proc Natl Acad Sci U S A 105:14377–14382. http://dx.doi.org/10.1073/pnas.0807988105.
   PubMed Web of Science ®Google Scholar
• Hu J, Stites EC, Yu H, Germino EA, Meharena HS, Stork PJS, Kornev AP, Taylor SS, Shaw AS. 2013. Allosteric activation of functionally asymmetric RAF kinase dimers. Cell 154:1036–1046. http://dx.doi.org/10.1016/j.cell.2013.07.046.
   PubMedGoogle Scholar
• Baccarini M. 2005. Second nature: biological functions of the Raf-1 “kinase.” FEBS Lett 579:3271–3277. http://dx.doi.org/10.1016/j.febslet.2005.03.024.
   PubMed Web of Science ®Google Scholar
• Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W. 2011. Raf family kinases: old dogs have learned new tricks. Genes Cancer 2:232–260. http://dx.doi.org/10.1177/1947601911407323.
   PubMedGoogle Scholar
• Morrison DK, Cutler RE. 1997. The complexity of Raf-1 regulation. Curr Opin Cell Biol 9:174–179. http://dx.doi.org/10.1016/S0955-0674(97)80060-9.
   PubMed Web of Science ®Google Scholar
• Ory S, Morrison DK. 2004. Signal transduction: IMPlications for Ras-dependent ERK signaling. Curr Biol 14:R277–R278. http://dx.doi.org/10.1016/j.cub.2004.03.023.
   PubMedGoogle Scholar
• Wimmer R, Baccarini M. 2010. Partner exchange: Protein-protein interactions in the Raf pathway. Trends Biochem Sci 35:660–668. http://dx.doi.org/10.1016/j.tibs.2010.06.001.
   PubMedGoogle Scholar
• Hu J, Yu H, Kornev AP, Zhao J, Filbert EL, Taylor SS, Shaw AS. 2011. Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF. Proc Natl Acad Sci U S A 108:6067–6072. http://dx.doi.org/10.1073/pnas.1102554108.
   PubMed Web of Science ®Google Scholar
• Gosal G, Kochut KJ, Kannan N. 2011. Prokino: an ontology for integrative analysis of protein kinases in cancer. PLoS One 6:e28782. http://dx.doi.org/10.1371/journal.pone.0028782.
   PubMedGoogle Scholar
• ManChon U, Talevich E, Katiyar S, Rasheed K, Kannan N. 2014. Prediction and prioritization of rare oncogenic mutations in the cancer kinome using novel features and multiple classifiers. PLoS Comput Biol 10:e1003545. http://dx.doi.org/10.1371/journal.pcbi.1003545.
   PubMedGoogle Scholar
• Qin J, Xie P, Ventocilla C, Zhou G, Vultur A, Chen Q, Liu Q, Herlyn M, Winkler J, Marmorstein R. 2012. Identification of a novel family of BRAF(V600E) inhibitors. J Med Chem 55:5220–5230. http://dx.doi.org/10.1021/jm3004416.
   PubMedGoogle Scholar
• Fiser A, Sali A. 2003. ModLoop: automated modeling of loops in protein structures. Bioinformatics 19:2500–2501. http://dx.doi.org/10.1093/bioinformatics/btg362.
   PubMed Web of Science ®Google Scholar
• Kornev AP, Taylor SS. 2009. Pseudokinases: functional insights gleaned from structure. Structure 17:5–7. http://dx.doi.org/10.1016/j.str.2008.12.005.
   PubMedGoogle Scholar
• Zhang BH, Guan KL. 2000. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J 19:5429–5439. http://dx.doi.org/10.1093/emboj/19.20.5429.
   PubMed Web of Science ®Google Scholar
• Rajakulendran T, Sahmi M, Lefrançois M, Sicheri F, Therrien M. 2009. A dimerization-dependent mechanism drives RAF catalytic activation. Nature 461:542–545. http://dx.doi.org/10.1038/nature08314.
   PubMed Web of Science ®Google Scholar
• Meharena HS, Chang P, Keshwani MM, Oruganty K, Nene AK, Kannan N, Taylor SS, Kornev AP. 2013. Deciphering the structural basis of eukaryotic protein kinase regulation. PLoS Biol 11:e1001680. http://dx.doi.org/10.1371/journal.pbio.1001680.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA. 2006. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311:1287–1290. http://dx.doi.org/10.1126/science.1124642.
   PubMedGoogle Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949–954. http://dx.doi.org/10.1038/nature00766.
   PubMed Web of Science ®Google Scholar
• Wan PTC, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Project CG, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R. 2004. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855–867. http://dx.doi.org/10.1016/S0092-8674(04)00215-6.
   PubMed Web of Science ®Google Scholar
• Scheeff ED, Eswaran J, Bunkoczi G, Knapp S, Manning G. 2009. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 17:128–138. http://dx.doi.org/10.1016/j.str.2008.10.018.
   PubMed Web of Science ®Google Scholar
• Shaw AS, Kornev AP, Hu J, Ahuja LG, Taylor SS. 2014. Kinases and pseudokinases: lessons learned from RAF. Mol Cell Biol 34:1538–1546. http://dx.doi.org/10.1128/MCB.00057-14.
   PubMed Web of Science ®Google Scholar
• Lanzarotti E, Biekofsky RR, Estrin DA, Marti MA, Turjanski AG. 2011. Aromatic-aromatic interactions in proteins: beyond the dimer. J Chem Infect Model 51:1623–1633. http://dx.doi.org/10.1021/ci200062e.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Akamine P, Radzio-Andzelm E, Madhusudan M, Taylor SS. 2001. Dynamics of cAMP-dependent protein kinase. Chem Rev 101:2243–2270. http://dx.doi.org/10.1021/cr000226k.
   PubMed Web of Science ®Google Scholar
• Iyer GH, Garrod S, Woods VL, Taylor SS. 2005. Catalytic independent functions of a protein kinase as revealed by a kinase-dead mutant: study of the Lys72His mutant of cAMP-dependent kinase. J Mol Biol 351:1110–1122. http://dx.doi.org/10.1016/j.jmb.2005.06.011.
   PubMedGoogle Scholar
• Steichen JM, Iyer GH, Li S, Saldanha SA, Deal MS, Woods VL, Taylor SS. 2010. Global consequences of activation loop phosphorylation on protein kinase A. J Biol Chem 285:3825–3832. http://dx.doi.org/10.1074/jbc.M109.061820.
   PubMedGoogle Scholar
• Steichen JM, Kuchinskas M, Keshwani MM, Yang J, Adams JA, Taylor SS. 2012. Structural basis for the regulation of protein kinase A by activation loop phosphorylation. J Biol Chem 287:14672–14680. http://dx.doi.org/10.1074/jbc.M111.335091.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137–1149. http://dx.doi.org/10.1016/j.cell.2006.05.013.
   PubMed Web of Science ®Google Scholar